These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12816906)
21. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Shi Q; Ling M; Zhang X; Zhang M; Kadijevic L; Liu S; Laurino JP Clin Chem; 1999 Jul; 45(7):1018-25. PubMed ID: 10388478 [TBL] [Abstract][Full Text] [Related]
22. Analytical and diagnostic performance of troponin assays in patients suspicious for acute coronary syndromes. Heeschen C; Deu A; Langenbrink L; Goldmann BU; Hamm CW Clin Biochem; 2000 Jul; 33(5):359-68. PubMed ID: 11018687 [TBL] [Abstract][Full Text] [Related]
23. Positive interference from contrast media in cardiac troponin I immunoassays. Lin CT; Lee HC; Voon WC; Yen HW; Tang MH; Chin TT; Chen WR; Chien WT; Lai WT; Sheu SH Kaohsiung J Med Sci; 2006 Mar; 22(3):107-13. PubMed ID: 16602274 [TBL] [Abstract][Full Text] [Related]
24. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays. Dasgupta A; Chow L; Wells A; Datta P J Clin Lab Anal; 2001; 15(4):175-7. PubMed ID: 11436198 [TBL] [Abstract][Full Text] [Related]
25. Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay. ver Elst KM; Chapelle JP; Boland P; Demolder JS; Gorus FK Am J Clin Pathol; 1999 Dec; 112(6):745-52. PubMed ID: 10587695 [TBL] [Abstract][Full Text] [Related]
26. A comparison of capture antibody fragments in cardiac troponin I immunoassay. Hyytiä H; Järvenpää ML; Ristiniemi N; Lövgren T; Pettersson K Clin Biochem; 2013 Aug; 46(12):963-968. PubMed ID: 23370114 [TBL] [Abstract][Full Text] [Related]
27. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
29. Analytical performance of the i-STAT cardiac troponin I assay. Apple FS; Murakami MM; Christenson RH; Campbell JL; Miller CJ; Hock KG; Scott MG Clin Chim Acta; 2004 Jul; 345(1-2):123-7. PubMed ID: 15193986 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. Storti S; Prontera C; Parri MS; Iervasi A; Vittorini S; Emdin M; Zucchelli GC; Longombardo G; Migliorini P; Clerico A Clin Chem Lab Med; 2006; 44(8):1022-9. PubMed ID: 16879072 [TBL] [Abstract][Full Text] [Related]
32. Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification. Herman DS; Ranjitkar P; Yamaguchi D; Grenache DG; Greene DN Clin Biochem; 2016 Oct; 49(15):1118-1121. PubMed ID: 27317886 [TBL] [Abstract][Full Text] [Related]
33. Upconverting nanophosphors as reporters in a highly sensitive heterogeneous immunoassay for cardiac troponin I. Sirkka N; Lyytikäinen A; Savukoski T; Soukka T Anal Chim Acta; 2016 Jun; 925():82-7. PubMed ID: 27188320 [TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535 [TBL] [Abstract][Full Text] [Related]
35. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference. Kazmierczak SC; Sekhon H; Richards C Int J Cardiol; 2005 May; 101(1):27-31. PubMed ID: 15860379 [TBL] [Abstract][Full Text] [Related]
36. Interaction of heparin with human cardiac troponin complex and its influence on the immunodetection of troponins in human blood samples. Riabkova NS; Bogomolova AP; Kogan AE; Katrukha IA; Vylegzhanina AV; Pevzner DV; Alieva AK; Bereznikova AV; Katrukha AG Clin Chem Lab Med; 2024 Oct; 62(11):2316-2325. PubMed ID: 38738903 [TBL] [Abstract][Full Text] [Related]
37. Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Qin QP; Kokkala S; Lund J; Tamm N; Qin X; Lepäntalo M; Pettersson K Clin Chem; 2006 Mar; 52(3):398-404. PubMed ID: 16423908 [TBL] [Abstract][Full Text] [Related]
38. New approach to standardisation of human cardiac troponin I (cTnI). Katrukha A; Bereznikova A; Pettersson K Scand J Clin Lab Invest Suppl; 1999; 230():124-7. PubMed ID: 10389210 [TBL] [Abstract][Full Text] [Related]
39. Monoclonal Antibodies Against Human Cardiac Troponin I for Immunoassays II. Lee G; Liu S Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):169-73. PubMed ID: 26090594 [TBL] [Abstract][Full Text] [Related]
40. Troponin I in patients without chest pain. Ritter D; Lee PA; Taylor JF; Hsu L; Cohen JD; Chung HD; Virgo KS Clin Chem; 2004 Jan; 50(1):112-9. PubMed ID: 14709640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]